Results from Optimizing Beta-Blocker Dosage in Female Patients Using the Wearable Cardioverter Defibrillator (OPT-BB Women) were presented at ESC-HF 2026CHELMSFORD, Mass.--(BUSINESS WIRE)--ZOLL®, an ...
Among patients with advanced HFrEF, women, compared with men, are less likely to receive an implantable cardiac defibrillator. Women who have advanced heart failure with reduced ejection fraction ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results